ADHD and the Adolescent Driver:

Driving is a dangerous undertaking for any adolescent. Automobile collisions account for 47% of all female and 37% of all male adolescent (16 to 19 years old) deaths in the United States.¹ In 2002, the cost of police- reported crashes (both fatal and nonfatal) involving drivers aged 15 to 20 years was $40.8 billion.²These collisions are 4 times more likely to occur at night.³ In addition, they are twice as likely to take place on weekends⁴ and more likely to happen during the summer.³

While this is disturbing enough, driving becomes even more problematic for adolescents who have attention deficit hyperactivity disorder (ADHD). Teenage drivers with ADHD are 8 times more likely to lose their license, 4 times more likely to be involved in a collision, 3 times more likely to sustain a serious injury, and 2 to 4 times more likely to receive a moving vehicle violation.^5,6 This is not surprising considering that the core symptoms of ADHD are inattention, impulsivity, and hyperactivity. Also, alcohol use commonly influences driving mishaps among adolescents; 24% of young drivers who died in crashes in 2002 had a blood alcohol level of 0.08% or higher.² Given the same blood alcohol levels, persons with ADHD have been shown to be more impaired while driving than those without ADHD.⁷

Pharmacologic Therapy

The good news is that methylphenidate has been shown to improve the driving performance of adolescents with ADHD--both in virtual-reality driving simulators in which drivers are exposed to high-risk driving demands⁸ and routine on-road driving in their own vehicle.⁵ Ours is the only group that has published studies that compare the efficacy of different medications on driving performance in adolescents with ADHD. Preliminary study results indicate that controlled-release OROS methylphenidate taken once a day improves driving performance significantly more in the evenings than short-acting methylphenidate taken 3 times a day or long-acting mixed amphetamine salts taken once a day.^8-10

In the only study that evaluated atomoxetine, the drug was found to improve self-reported driving ability but not simulated driving performance.¹¹ Another pilot study suggests the arousal and attention demand of a manual transmission may enhance the attention of ADHD adolescent drivers and promote safer driving than automatic transmissions.¹²

Two other articles offer in-depth reviews.^13,14

Initiating and Monitoring Therapy

Before considering treatment options, it might be useful to review the diagnosis of ADHD. The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) outlines diagnostic criteria for childhood ADHD.¹⁵ We have converted these criteria to be adolescent-relevant (Table 1). To qualify for a diagnosis of ADHD, a patient must have had at least 6 symptoms in the inattentive or 6 symptoms in the impulsive/hyperactive categories in at least 2 areas of their lives (eg, school, work, home) since age 6. These behaviors must occur often, not just periodically. Adolescents may qualify for the inattentive, impulsive/hyperactive, or the combined subtype. Consider stimulant medication therapy only if the adolescent meets the criteria for one of these subtypes.

Treatment should involve a long-acting stimulant medication, which may need to be supplemented with short-acting methylphenidate if the adolescent drives more than 15 hours after ingesting OROS methylphenidate. The dosage should be increased until there is no further improvement in ADHD symptoms or unacceptable adverse side effects develop.

Clinicians typically strive to optimize the dosage of medication used to manage such chronic diseases as asthma and epilepsy. However, we sometimes adjust the dosage in patients with ADHD only until beneficial effect is detected. To evaluate whether symptoms are responding to the medication, it is not enough to rely on simple global reports, such as, "things are a lot better." It is more helpful to systematically review and record the symptoms shown in Table 1 before starting any medication, and then after each increase in medication dose. It is not unusual to find that one set of symptoms improves with a lower dose and a different cluster of symptoms improves with a higher dose. The patient, parent, and/or teacher may describe especially worrisome symptoms that also need to be monitored.

Adherence

Medication holidays are not indicated for adolescents who drive. If adolescents take long-acting medications year-round, high-risk driving periods (ie, evenings, weekends, and summer vacation) are covered.

When an adolescent does not adhere to daily therapy (because of lack of effect or unpleasant adverse effects), consider adjusting the dosage or prescribing an alternative medication. If non-adherence is attributed to "forgetfulness," then a plan is needed in which the adolescent is reminded to take his or her medication first thing in the morning. For example, it may be useful to put the medication in one's shaving kit or to set one's cell phone alarm as a prompt.

For adolescents disinclined to take medication, it can be useful to have them keep a driving diary for a medication-free period and for a similar period when they are taking optimally dosed medications, as an "experiment." A review of a diary (Table 2) may offer objective evidence that the patient drives more safely when taking medication. Patients also may be motivated to take medication if parents have the teen driver pay for his own car insurance and any expenses resulting from a driving mishap (eg, repairs, court and lawyer fees, and fines).

In attempting to persuade adolescents to take medication daily, remind them that just as they may have to wear glasses all the time while driving to optimize performance, they also need ADHD medication to optimize their performance.

Research suggests that younger drivers are motivated more by legal and fiscal consequences, whereas older drivers may be more motivated by risk to their physical well-being.¹⁶ Thus, it may not be useful to threaten the adolescent with loss of life or physical injury but rather have him consider the possible consequences of having his license suspended for 6 months, not being able to drive on a date, having to pay increased insurance rates, or not being able to play a favorite sport or to participate in a favorite activity because of some debilitating injury.

While coercion is never a good foundation on which to compel an adolescent into compliance, rules can be established between the parent and teen. For example, the car keys are only available if medication has been taken or the car insurance will not be paid unless the teen routinely takes his medication.

Non-medical Interventions

It can be useful to have parent and adolescent read, understand, and sign an agreement of understanding (Table 3). Such an agreement has several advantages. Because patients generally retain only about half of what they have been told in a consultation room,¹⁷ a written statement ensures they will have this information once they get home. An agreement educates the parties as to the significance that adolescence, ADHD, and medication play in driving safety. A signature emphasizes the importance you place in these issues. Patients and parents are making a personal recognition that they understand this information--not that they necessarily agree with it. Your copy of the agreement serves as documentation that your patient has been informed of the risks related to driving.

Also, advise patients (and parents) to reduce potential distractions while driving (Table 4). Drivers with ADHD tend to be more distracted than drivers without ADHD. As such, measures to reduce potential distractions may lower risk. For example, ADHD drivers should select their radio station or CD before starting to drive.¹⁸ Cell phones should be turned off while driving.

Because basic driving skills are acquired during the first 6 months of independent driving and the risk for accidents is high, there should be no teenage passengers to distract the driver. This is important because for every teenage passenger in a car driven by a teenager, death rates increase 130%.³ There should be no eating or drinking in the car, both because these activities can be distracting (particularly if the items fall to the floor) and can block vision. The patient should know the route to his destination before initiating a trip so that it will not be necessary to look at maps or for street addresses or signs while driving.

Teenagers with ADHD receive more moving vehicle violations (in particular, speeding tickets) than their non-ADHD counterparts.^13,14 Therefore, teens should be reminded not to speed. Inattention can be especially problematic when a driver is speeding and tailgating. Because adolescent driving accidents are 4 times more common after 9 pm,³ evening driving during the first 6 months of independent driving should be significantly restricted. However, most important are both good role modeling by parent drivers and supportive and positive counseling by responsible adult drivers.

There are studies demonstrating that driving with a manual transmission is more stimulating than with an automatic transmission. One pilot study involved 10 adolescents with ADHD who drove a virtual-reality driving simulator in both the automatic mode and the 4-speed manual mode at 8 pm and 11 pm.¹² These participants reported being more alert when driving in manual mode; objective measures showed they drove more safely than with an automatic transmission.¹²

The pilot study was preceded by clinical reports of adolescents with ADHD who said they were less able to daydream when driving a manual transmission. For example, an adolescent reported, "If I don't pay attention to what I'm doing, the car will jerk and stall, and, boy, is that embarrassing." Although using a manual transmission may be a possible non-pharmacological intervention, it may take ADHD adolescents longer to learn how to coordinate use of the clutch and gearshift. It could be that manual transmission may be even more beneficial when using stimulant medications. It could be counterproductive for an ADHD adolescent to drive a manual transmission if he uses this as a mode to engage in reckless driving (eg, "burn rubber," or beat another driver "off the line").

References:

REFERENCES:

1. Insurance Institute for Highway Safety. Fatality Facts 2004: Teenagers. Available at:

http://www.iihs.org/research/fatality_facts/pdfs/teenagers.pdf

. Accessed December 6, 2006.
2. Traffic Safety Facts 2002. Young Drivers, National Highway Traffic Safety Administration, DOT HS 809 619. Available at:

http://www-nrd.nhtsa.dot.gov/pdf/nrd-30/NCSA/TSF2002/2002ydrfacts.pdf

. Accessed December 12, 2006.
3. National Center for Statistics and Analysis, National Highway Traffic Safety Administration. Fatality Analysis Reporting System (FARS) Web-based Encyclopedia. Available online at

http://www-fars.nhtsa.dot.gov/main.cfm

. Accessed December 6, 2006.
4. National Highway Transportation Safety Administration. Report--Teens at Risk. Available at:

http://www-cdc.gov/ncipc/factsheets/teenmvh.htm

. Accessed December 6, 2006.
5. Barkley RA, Murphy KR, Kwasnik D. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder.

Pediatrics

. 1996;98:1089-1095.
6. Barkley RA, Guevremont DC, Anastopoulos AD, et al. Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey.

Pediatrics

. 1993;92:212-218.
7. Barkley RA, Murphy KR, O'Connell T, et al. Effects of two doses of alcohol on simulator driving performance in adults with attention-deficit/hyperactivity disorder.

Neuropsychology.

2006;20:77-87.
8. Cox DJ, Merkel RL, Moore M, et al. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/ hyperactivity disorder.

Pediatrics.

2006;118:e704-e710.
9. Cox DJ, Humphrey JW, Merkel RL, et al. Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder.

J Am Board Fam Pract

. 2004;17:235-239.
10. Cox DJ, Merkel RL, Kovatchev B, Seward R. Effect of stimulant medication on driving performance of young adults with attention-deficit/hyperactivity disorder: a preliminary double-blind placebo controlled trial.

J Nerv Ment Dis.

2000;188:230-234.
11. Barkley RA, Anderson DL, Kruesi M. A pilot study of atomoxetine on driving performance in adults with attention deficit hyperactivity disorder (ADHD).

J Atten Disord.

2006. In press.
12. Cox DJ, Punja M, Powers K, et al. Manual transmission enhances attention and driving performance of ADHD adolescent males: pilot study.

J Atten Disord

. 2006;10:212-216.
13. Jerome L, Habinski L, Segal A. Attention-deficit/ hyperactivity disorder (ADHD) and driving risk: a review of the literature and a methodological critique.

Curr Psychiatry Rep

. 2006;8:416-426.
14. Barkley RA, Cox D. A review of driving performance and adverse outcomes in adolescents and adults with attention deficit/hyperactivity disorder.

J Safety Res

. 2007. In press.
15. American Psychiatric Association.

Diagnostic and Statistical Manual of Mental Disorders.

4th ed. Washington, DC: American Psychiatric Association; 2000:85-93.
16. Quillian WC, Cox DJ, Kovatchev B, Phillips C. The effects of age and alcohol intoxication on simulated driving performance, awareness and self- restraint.

Age Ageing

1999;28:59-66.
17. Cox DJ, Tisdelle DA, Culbert JP. Increasing adherence to behavioral homework assignments.

J Behav Med

. 1988;11:519-522.
18. Laberge J, Ward N, Manser M, et al. Driving skills among ADHD drivers: Preliminary research. Unpublished manuscript.